PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 104 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 250 | -92.2% | 0.00% | -100.0% |
| Q2 2023 | $23 | +187.5% | 3,200 | +3.2% | 0.00% | +200.0% |
| Q1 2023 | $8 | +100.0% | 3,100 | +675.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 400 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -20.0% | 400 | -33.3% | 0.00% | – |
| Q2 2022 | $5,000 | -37.5% | 600 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 600 | -33.3% | 0.00% | – |
| Q4 2021 | $11,000 | -42.1% | 900 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $19,000 | -17.4% | 900 | +28.6% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | -11.5% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $26,000 | +160.0% | 700 | +75.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |